Propecia is a brand-name medication that contains finasteride as its active ingredient. Finasteride belongs to the class of drugs known as 5-α-reductase inhibitors and is used primarily in men’s health. In Hong Kong, Propecia is a prescription-only product (Rx) marketed for the treatment of male pattern hair loss (androgenetic alopecia). The medication is supplied as a pill and is available in two strengths: 1 mg (the standard dose for hair loss) and 5 mg (commonly used for benign prostatic hyperplasia, though this higher dose is not labeled for hair-loss treatment).
Finasteride blocks the enzyme 5-α-reductase, which converts the hormone testosterone into dihydrotestosterone (DHT). DHT is the main androgen responsible for shrinking hair follicles on the scalp in genetically predisposed men. By reducing DHT levels:
The medication is taken orally, absorbed through the gastrointestinal tract, and reaches peak blood concentrations within 2-6 hours. Its effects on DHT are sustained with daily dosing; however, visible improvement in hair growth typically becomes noticeable after 3-6 months of continuous use.
Male pattern hair loss (androgenetic alopecia)
While the 5 mg tablet is approved in many jurisdictions for benign prostatic hyperplasia (BPH), Propecia is marketed only in the 1 mg strength for hair loss. Consequently, the 5 mg tablet is generally prescribed as a separate product (e.g., Proscar) and not as Propecia.
Finasteride has been studied off-label for several conditions, including:
Disclaimer: Off-label use requires close medical supervision, individualized risk assessment, and is not endorsed by Hong Kong regulatory agencies.
These effects are generally mild and reversible after discontinuation.
If you take multiple medications, inform your healthcare provider before starting Propecia.
This article provides educational information about Propecia and is not a substitute for professional medical advice. Treatment decisions, including the use of unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Finasteride can be combined with topical minoxidil, but you should discuss the full regimen with a dermatologist or pharmacist to avoid overlapping side effects and to ensure proper timing.
Visible improvement typically appears after 3-6 months of daily use, with maximal benefit often reached after 12 months. Stopping the medication will usually result in a gradual return to the pre-treatment state within a year.
Finasteride at the 1 mg dose is generally safe for men with benign prostatic hyperplasia, but the 5 mg formulation is preferred for that condition. Always have prostate health evaluated before initiating therapy.
Yes. Finasteride reduces PSA levels by about 50 %. When interpreting PSA results, physicians should double the measured value to approximate the true PSA level.
No specific dietary restrictions exist. However, maintaining a balanced diet supports overall hair health and may improve treatment outcomes.
Finasteride is excreted in small amounts in semen; the risk to a female partner is considered negligible, but oral exposure (e.g., swallowing semen) should be avoided during pregnancy due to teratogenic risk.
Report the symptoms to your healthcare provider. In many cases, side effects lessen over time, but a dosage adjustment or alternative therapy may be considered.
Yes. Propecia is a prescription-only medication in Hong Kong and must be obtained through a licensed healthcare professional.
Carry the medication in its original packaging with a copy of the prescription. Some countries require documentation for hormone-affecting drugs; check the destination’s import regulations in advance.
Finasteride works systemically by lowering DHT, while minoxidil promotes hair growth locally through vasodilation. Many clinicians recommend using both for synergistic benefits, but they target different pathways.
